BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2750107)

  • 1. [Immunity in children having had viral hepatitis A and been treated with various immunomodulators in the acute period].
    Vereshchagin IA; Koliagina NT; Bobrovitskaia AI
    Vrach Delo; 1989 Mar; (3):118-20. PubMed ID: 2750107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of amben on the immunological reactivity indices in viral hepatitis A].
    Litvinenko NG
    Vrach Delo; 1984 Oct; (10):113-6. PubMed ID: 6334935
    [No Abstract]   [Full Text] [Related]  

  • 3. [Characteristics of various indicators of cellular immunity during the convalescence period of viral hepatitis in children].
    Spiridonova EA
    Lab Delo; 1978; (10):590-3. PubMed ID: 81909
    [No Abstract]   [Full Text] [Related]  

  • 4. [The immunocorrective therapy of patients with viral hepatitis A living under the adverse conditions of an industrial region].
    Frolov VM; Peresadin NA; Pustovoĭ IuG; Dorofeev SM
    Vrach Delo; 1991 Aug; (8):77-80. PubMed ID: 1949744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of potassium orotate on the clinical laboratory indices of viral hepatitis in children].
    Bogatyreva SA
    Pediatr Akus Ginekol; 1975; (4):22-4. PubMed ID: 1228630
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of prodigiozan and zymosan in treating children with viral hepatitis A].
    Lebenzon SS; Maianskiĭ DN; Gavrilova NI; Kutina SN
    Pediatriia; 1988; (6):27-30. PubMed ID: 3186403
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in the nonspecific immunobiological reactivity of young children with acute pneumonia under the influence of metacil].
    Nakonechnyĭ VF
    Pediatr Akus Ginekol; 1975; (1):7-9. PubMed ID: 778770
    [No Abstract]   [Full Text] [Related]  

  • 8. [Corticosteroids in viral hepatitis (author's transl)].
    Blanco A; Andión R; Solís P; Blanco S; Sánchez Villares E
    An Esp Pediatr; 1976; 9(1):48-52. PubMed ID: 1267301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of cellular immunity in children with acute viral hepatitis A].
    Budarina NA; Belaia OF; Chulanov VP; Paĭmanov NV; Pak SG
    Ter Arkh; 2003; 75(11):31-5. PubMed ID: 14708438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of dibasol for preventing acute intestinal diseases and viral hepatitis A].
    Rakhmanov RS; Nazarov AP; Ponomareva NG; Dorofeeva VI
    Voen Med Zh; 1989 Jul; (7):50-1. PubMed ID: 2815620
    [No Abstract]   [Full Text] [Related]  

  • 11. [Frequency of detecting Australia antigen at different phases of the disease of viral hepatitis in children].
    Gol'zand IV; Blagoslovenskiĭ GS
    Vopr Okhr Materin Det; 1973 Sep; 18(9):12-5. PubMed ID: 4206062
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experience in the use of present day immunomodulators for prophylaxis of exacerbations of chronic adenoiditis and development of pharyngeal tonsil hypertrophy in poor health children].
    Vavilova VP
    Vestn Otorinolaringol; 2003; (3):44-7. PubMed ID: 12847808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunotherapy for the treatment of acute appendicitis in children].
    Bulanova AA; Akhanzaripov ZA
    Khirurgiia (Mosk); 1994 Aug; (8):34-6. PubMed ID: 7990319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinicoimmunological evaluation of the use of timogeksin in different forms of measles].
    Ershova IB
    Lik Sprava; 1997; (6):147-51. PubMed ID: 9589963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Australia antigen in the serum of children with viral hepatitis].
    Oziemska-Lozińska H; Dobrzyński L
    Pediatr Pol; 1973; 48(10):1185-90. PubMed ID: 4760692
    [No Abstract]   [Full Text] [Related]  

  • 16. [The antioxidant correction of cytogenetic disorders in viral hepatitis].
    Peresadin NA; Frolov VM; Pinskiĭ LL
    Lik Sprava; 1995; (1-2):76-9. PubMed ID: 7483554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A relapsing and protracted form of viral hepatitis A: comparison of adults and children].
    Stránský J; Honzáková E; Vandasová J; Kyncl J
    Vnitr Lek; 1995 Aug; 41(8):525-30. PubMed ID: 7483334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Protracted viral hepatitis (hepatitis virusalis forma prolongata) in children].
    Jung H
    Pediatr Pol; 1979 Mar; 54(3):249-53. PubMed ID: 450496
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatitis-bound Australia antigen and specific antiviral immunity in children with chronic diseases].
    Lozovskiĭ LS; Kasavina MA; Nisevich LL; Soboleva VD; Shigina OM
    Sov Med; 1973 May; 36(5):7-12. PubMed ID: 4203440
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of prednisone treatment in the acute phase of viral hepatitis on the incidence of late post-hepatitic hepatorpathy from 1 to 3 years after the disease. (Statistical evaluation of 187 cases)].
    Da Villa G; Fiorentino F; Piccinino F
    G Mal Infett Parassit; 1966 Dec; 18(12):835-40. PubMed ID: 5998986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.